J. B. Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM)
India
· Delayed Price · Currency is INR 1,743.40
+41.35 (2.43%)
Nov 22, 2024, 3:29 PM IST
JBCHEPHARM Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 37,113 | 34,842 | 31,493 | 24,242 | 20,425 | 17,747 | Upgrade
|
| Revenue Growth (YoY) | 11.35% | 10.63% | 29.91% | 18.69% | 15.09% | 8.00% | Upgrade
|
| Cost of Revenue | 12,842 | 12,142 | 11,963 | 8,655 | 7,227 | 6,525 | Upgrade
|
| Gross Profit | 24,270 | 22,700 | 19,530 | 15,588 | 13,198 | 11,222 | Upgrade
|
| Selling, General & Admin | 8,516 | 8,111 | 7,278 | 5,662 | 4,258 | 4,068 | Upgrade
|
| Other Operating Expenses | 6,075 | 5,661 | 5,190 | 4,460 | 3,358 | 3,308 | Upgrade
|
| Operating Expenses | 16,165 | 15,156 | 13,612 | 10,849 | 8,303 | 8,040 | Upgrade
|
| Operating Income | 8,105 | 7,544 | 5,918 | 4,739 | 4,895 | 3,182 | Upgrade
|
| Interest Expense | -289.22 | -436.52 | -347.68 | -40.85 | -67.43 | -29.17 | Upgrade
|
| Interest & Investment Income | 44.26 | 44.26 | 25.39 | 9.39 | 17.79 | 41.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 44.07 | 44.07 | -110.87 | -38.01 | 42.34 | -67.37 | Upgrade
|
| Other Non Operating Income (Expenses) | 19.71 | -5.79 | -2.79 | 1.06 | 50.88 | 64.44 | Upgrade
|
| EBT Excluding Unusual Items | 7,924 | 7,190 | 5,482 | 4,671 | 4,939 | 3,191 | Upgrade
|
| Gain (Loss) on Sale of Investments | 327.43 | 327.43 | 69 | 350.43 | 505.5 | 379.97 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.32 | -2.32 | 0.07 | 24.05 | 524.37 | 17.88 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -100 | Upgrade
|
| Other Unusual Items | - | - | 1.28 | 3.98 | - | - | Upgrade
|
| Pretax Income | 8,249 | 7,515 | 5,552 | 5,049 | 5,969 | 3,489 | Upgrade
|
| Income Tax Expense | 2,138 | 1,989 | 1,452 | 1,189 | 1,484 | 765 | Upgrade
|
| Earnings From Continuing Operations | 6,111 | 5,526 | 4,100 | 3,860 | 4,485 | 2,724 | Upgrade
|
| Minority Interest in Earnings | - | - | -1.7 | -6.82 | -5.59 | -3.45 | Upgrade
|
| Net Income | 6,111 | 5,526 | 4,098 | 3,854 | 4,480 | 2,720 | Upgrade
|
| Net Income to Common | 6,111 | 5,526 | 4,098 | 3,854 | 4,480 | 2,720 | Upgrade
|
| Net Income Growth | 25.58% | 34.84% | 6.35% | -13.98% | 64.66% | 40.62% | Upgrade
|
| Shares Outstanding (Basic) | 155 | 155 | 155 | 155 | 155 | 159 | Upgrade
|
| Shares Outstanding (Diluted) | 159 | 159 | 157 | 155 | 155 | 159 | Upgrade
|
| Shares Change (YoY) | 0.87% | 1.26% | 1.23% | 0.09% | -2.86% | -3.21% | Upgrade
|
| EPS (Basic) | 39.39 | 35.66 | 26.50 | 24.93 | 28.98 | 17.10 | Upgrade
|
| EPS (Diluted) | 38.43 | 34.85 | 26.17 | 24.91 | 28.98 | 17.10 | Upgrade
|
| EPS Growth | 24.51% | 33.17% | 5.06% | -14.04% | 69.50% | 45.27% | Upgrade
|
| Free Cash Flow | 6,724 | 6,629 | 5,562 | 1,073 | 2,670 | 2,028 | Upgrade
|
| Free Cash Flow Per Share | 42.28 | 41.80 | 35.51 | 6.93 | 17.28 | 12.74 | Upgrade
|
| Dividend Per Share | 6.750 | 12.250 | 8.875 | 8.250 | 8.250 | 5.500 | Upgrade
|
| Dividend Growth | -33.33% | 38.03% | 7.58% | 0% | 50.00% | 120.00% | Upgrade
|
| Gross Margin | 65.40% | 65.15% | 62.01% | 64.30% | 64.62% | 63.23% | Upgrade
|
| Operating Margin | 21.84% | 21.65% | 18.79% | 19.55% | 23.97% | 17.93% | Upgrade
|
| Profit Margin | 16.47% | 15.86% | 13.01% | 15.90% | 21.93% | 15.33% | Upgrade
|
| Free Cash Flow Margin | 18.12% | 19.03% | 17.66% | 4.42% | 13.07% | 11.43% | Upgrade
|
| EBITDA | 9,649 | 8,896 | 7,038 | 5,384 | 5,498 | 3,757 | Upgrade
|
| EBITDA Margin | 26.00% | 25.53% | 22.35% | 22.21% | 26.92% | 21.17% | Upgrade
|
| D&A For EBITDA | 1,543 | 1,352 | 1,120 | 645.45 | 602.84 | 575.13 | Upgrade
|
| EBIT | 8,105 | 7,544 | 5,918 | 4,739 | 4,895 | 3,182 | Upgrade
|
| EBIT Margin | 21.84% | 21.65% | 18.79% | 19.55% | 23.97% | 17.93% | Upgrade
|
| Effective Tax Rate | 25.92% | 26.46% | 26.16% | 23.54% | 24.86% | 21.93% | Upgrade
|
| Revenue as Reported | 37,511 | 35,214 | 31,592 | 24,635 | 21,549 | 18,254 | Upgrade
|
| Advertising Expenses | - | 2,077 | 1,808 | 1,250 | 838.21 | 826.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.